Providence Health & Services
Clinical trials sponsored by Providence Health & Services, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Supercharged immune cells take on incurable tumors Results expected Dec 2026 (estimated)
- New combo therapy aims to shrink head and neck tumors before surgery Results expected Jan 2027 (estimated)
- Custom-Made immune cells take on incurable tumors Results expected Apr 2027 (estimated)
- Experimental drug combo aims to shrink aggressive breast tumors before surgery Results expected Jun 2027 (estimated)
-
New shot aims to stop breast cancer before it starts
Disease control Not yet recruitingThis early-phase trial tests a drug called CAN1012 in 24 people with pre-cancerous breast conditions (DCIS or LCIS). The drug is injected directly into the lesion to activate the immune system. The main goal is to check safety and ensure the treatment doesn't delay necessary surg…
Phase 1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New shot aims to stop mouth lesions before they become cancer
Disease control Not yet recruitingThis early-phase trial tests a drug called CAN1012, which is injected directly into pre-cancerous mouth lesions. The goal is to see if it is safe and can activate the immune system to fight the abnormal cells. The study involves 36 adults with oral epithelial dysplasia who will r…
Phase 1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC